Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to FBN1: Fibrillin, Marfan syndrome
FBN1Fibrillin 1
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Studies have demonstrated a higher probability of cardiovascular events in patients with mutations reducing the amount of FBN1 (classified as HI mutation).
Transmission of GD is variable and corresponds to an autosomal recessive model in the cases with ADAMTSL2 gene mutations and an autosomal dominant model in the cases with FBN1 and LTBP3 mutations [1, 7].
Large intragenic deletions in the FBN1 gene have been detected in approximately 2% of individuals with MFS who did not have a pathogenic variant identified by sequence analysis [14].
Van Acker et al., "Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome," Human Mutation, vol.
In FBN1 hypomorphic mice (mgR/mgR displayed a 70% decrease in circulating asprosin), proinflammatory cytokines were elevated and contributed to the formation of inflammatory diseases, such as aortic aneurysms [19].
Jhangiani et al., "FBN1 contributing to familial congenital diaphragmatic hernia," American Journal of Medical Genetics Part A, vol.
The DNA extracted from peripheral blood and Sanger sequencing, demonstrated a heterozygous missense mutation c.3037G>A in exon 24 of the FBN1 gene (NM_000138) resulting in a non-conservative substitution of a glycine residue for arginine (p.G1013R).
FBN1 El registrador chequea si el aspirante ya existe en el Archivo de Estudiantes y determina que el aspirante no existe en el Archivo.
determined that the presence of hypermethylation in at least one of the genes SNCA and FBN1 was found to have a sensitivity and specificity of 84.3% and 93.3%, respectively [35].
It is inherited in an autosomal dominant fashion and is mostly due to a mutation of the FBN1 gene on chromosome 15 that encodes the protein fibrillin-1.
A recent study found that miR29 acts as an antifibrotic factor by accelerating the expression of multiple extracellular matrix genes including elastin [61], fibrillin 1 (Fbn1), collagen type I, [alpha] 1 and 2 (Col1[alpha]1, Col1[alpha]2), collagen type III, [alpha]1 (Col3[alpha]1), and fibronectin (FBN) [62,63].
Genetics testing of the following genes was performed, though no pathogenic mutations or clinically significant variants were detected: ACTA2, CBS, COL3A1, FBN1, FBN2, MYH11, SLC2A10, SMAD3, TGFBR1 and TGFBR2.